Halozyme’s “Hat Collector” Approach To Human Capital: Virtue in Versatility

A Q&A on biopharma workforce recruitment, training and C-suite oversight with Halozyme's Ken Schultz, MD. A supplement to our feature on the In Vivo/EBD Academy survey, "Future-Proofing Human Capital in the Global Life Sciences: Does Biopharma Have the Right Stuff?

More from Leadership

More from In Vivo